Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
eli lilly
3
×
indiana blog main
indiana top stories
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
wisconsin blog main
wisconsin top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
johnson & johnson
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
alector
alex azar
alexion pharmaceuticals
alkermes
alliance for aging research
alnylam pharmaceutials
amgen
arrowhead pharmaceuticals
avrobio
baricitinib
What
pharma
3
×
abandoning
administration
ago
angry
anti
baggage
benefited
bio
biopharma
companies
congress
congressional
crispr
cuts
deal
despite
development
dicerna
drug
executives
fear
feud
free
gets
group
industry
interference
isn’t
known
later
long
losing
medicines
month
new
ny
plans
presidential
price
Language
Current search:
pharma
×
" eli lilly "
×
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M